Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
66 GF Score
Price NT$33.65
GF Value NT$38.04
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co SpecialCharges?

Special Charges only applies to banks.

TPE:1762
66GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be undervalued. The current stock price of NT$33.65 is trading 11.5% below its estimated GF Value™ of NT$38.04. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:1762:

  • SpecialCharges:
  • GF Value™: NT$38.04 vs. price of NT$33.65 (11.5% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is a Taiwanese pharmaceutical manufacturer engaged in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio spans pain management, antifungal, immunosuppressant, oncology, cardiovascular, and peptide drugs, serving both generic and specialty pharmaceutical markets. The company operates manufacturing facilities in Taiwan and supplies pharmaceutical companies, including generic drug makers and research organizations, in the United States, Taiwan, and other international markets. A significant portion of its revenue is derived from export sales, particularly to the United States, with additional revenue from domestic Taiwanese customers. Its business model combines contract manufacturing and development services with sales of its own generic and specialty pharmaceutical products, generating income through API supply, finished drug sales, and CDMO arrangements with partners worldwide.
66GF Score

Get the complete analysis for TPE:1762

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.65
Price
NT$38.04
GF Value